Harbin Pharmaceutical Group Co., Ltd. (600664.SS)
CNY 3.97
(0.0%)
CNY 3.97
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.02 Billion CNY | -11.17% |
| 2022 | 1.12 Billion CNY | 15.14% |
| 2021 | 1.06 Billion CNY | 3153.45% |
| 2020 | -378.69 Million CNY | -102.94% |
| 2019 | 769.48 Million CNY | -16.59% |
| 2018 | 1.05 Billion CNY | -1.09% |
| 2017 | 1.12 Billion CNY | -28.34% |
| 2016 | 1.53 Billion CNY | 10.41% |
| 2015 | 1.28 Billion CNY | 51.22% |
| 2014 | 795.22 Million CNY | 3.7% |
| 2013 | 760.04 Million CNY | -25.6% |
| 2012 | 1.25 Billion CNY | 10.66% |
| 2011 | 1.18 Billion CNY | -29.44% |
| 2010 | 1.66 Billion CNY | 19.59% |
| 2009 | 1.35 Billion CNY | -5.95% |
| 2008 | 1.43 Billion CNY | 37.48% |
| 2007 | 1.04 Billion CNY | -3.11% |
| 2006 | 1.12 Billion CNY | 2.69% |
| 2005 | 1.09 Billion CNY | 53.87% |
| 2004 | 713.41 Million CNY | -10.23% |
| 2003 | 791.95 Million CNY | 12.7% |
| 2002 | 702.71 Million CNY | 10.25% |
| 2001 | 637.39 Million CNY | 9.93% |
| 2000 | 548.87 Million CNY | 27.51% |
| 1999 | 434.67 Million CNY | 25.74% |
| 1998 | 335.18 Million CNY | 57.74% |
| 1997 | 229.25 Million CNY | 0.62% |
| 1996 | 227.84 Million CNY | -2.67% |
| 1995 | 234.09 Million CNY | -86.69% |
| 1994 | 1.75 Billion CNY | 623.44% |
| 1993 | 243.17 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 260.91 Million CNY | 26.48% |
| 2024 Q2 | 287.94 Million CNY | -6.29% |
| 2024 Q3 | 255.84 Million CNY | -18.11% |
| 2023 Q1 | 211.33 Million CNY | -23.44% |
| 2023 FY | - CNY | -11.17% |
| 2023 Q2 | 148.38 Million CNY | -29.79% |
| 2023 Q4 | 237.17 Million CNY | 25.11% |
| 2023 Q3 | 189.57 Million CNY | 27.76% |
| 2022 Q3 | 135.86 Million CNY | 13.11% |
| 2022 FY | - CNY | 15.14% |
| 2022 Q4 | 276.04 Million CNY | 103.18% |
| 2022 Q2 | 120.12 Million CNY | -37.29% |
| 2022 Q1 | 191.55 Million CNY | 304.57% |
| 2021 Q4 | -93.64 Million CNY | -134.83% |
| 2021 FY | - CNY | 3153.45% |
| 2021 Q3 | 268.85 Million CNY | 8.37% |
| 2021 Q1 | 167.22 Million CNY | 130.94% |
| 2021 Q2 | 248.08 Million CNY | 48.35% |
| 2020 Q4 | -540.42 Million CNY | -1740.12% |
| 2020 FY | - CNY | -102.94% |
| 2020 Q1 | -121.67 Million CNY | -174.49% |
| 2020 Q2 | 68.05 Million CNY | 155.93% |
| 2020 Q3 | 32.95 Million CNY | -51.58% |
| 2019 Q2 | 166.81 Million CNY | 415.4% |
| 2019 FY | - CNY | -16.59% |
| 2019 Q4 | 163.34 Million CNY | 24.86% |
| 2019 Q1 | -52.89 Million CNY | -130.09% |
| 2019 Q3 | 130.82 Million CNY | -21.57% |
| 2018 Q3 | -40.4 Million CNY | -113.06% |
| 2018 Q2 | 309.47 Million CNY | 59.81% |
| 2018 Q4 | 175.79 Million CNY | 535.06% |
| 2018 FY | - CNY | -1.09% |
| 2018 Q1 | 193.65 Million CNY | -30.51% |
| 2017 Q1 | 73.88 Million CNY | -83.18% |
| 2017 FY | - CNY | -28.34% |
| 2017 Q3 | -13.41 Million CNY | -103.16% |
| 2017 Q4 | 278.67 Million CNY | 2177.08% |
| 2017 Q2 | 423.99 Million CNY | 473.88% |
| 2016 Q2 | 391.21 Million CNY | 192.76% |
| 2016 Q3 | 271.22 Million CNY | -30.67% |
| 2016 Q4 | 439.24 Million CNY | 61.95% |
| 2016 FY | - CNY | 10.41% |
| 2016 Q1 | 133.63 Million CNY | -60.31% |
| 2015 Q3 | 74.23 Million CNY | -75.81% |
| 2015 FY | - CNY | 51.22% |
| 2015 Q4 | 336.69 Million CNY | 353.52% |
| 2015 Q2 | 306.89 Million CNY | 10.11% |
| 2015 Q1 | 278.71 Million CNY | 68.11% |
| 2014 Q3 | 6.91 Million CNY | -96.87% |
| 2014 Q4 | 165.79 Million CNY | 2297.39% |
| 2014 FY | - CNY | 3.7% |
| 2014 Q1 | 209.74 Million CNY | 137.1% |
| 2014 Q2 | 221.06 Million CNY | 5.39% |
| 2013 Q4 | 88.46 Million CNY | -25.54% |
| 2013 Q2 | 72.45 Million CNY | -73.19% |
| 2013 Q3 | 118.8 Million CNY | 63.98% |
| 2013 Q1 | 270.21 Million CNY | 33.77% |
| 2013 FY | - CNY | -25.6% |
| 2012 Q4 | 201.99 Million CNY | 116.63% |
| 2012 FY | - CNY | 10.66% |
| 2012 Q1 | 340.39 Million CNY | 394.57% |
| 2012 Q2 | 12.97 Million CNY | -96.19% |
| 2012 Q3 | 93.24 Million CNY | 618.83% |
| 2011 Q3 | 207.09 Million CNY | -53.73% |
| 2011 Q2 | 447.54 Million CNY | 23.49% |
| 2011 Q1 | 362.4 Million CNY | -4.1% |
| 2011 FY | - CNY | -29.44% |
| 2011 Q4 | -115.55 Million CNY | -155.8% |
| 2010 FY | - CNY | 19.59% |
| 2010 Q2 | 342.22 Million CNY | 7.33% |
| 2010 Q3 | 301.15 Million CNY | -12.0% |
| 2010 Q4 | 377.9 Million CNY | 25.48% |
| 2010 Q1 | 318.84 Million CNY | 88.96% |
| 2009 Q4 | 168.73 Million CNY | -43.53% |
| 2009 FY | - CNY | -5.95% |
| 2009 Q3 | 298.79 Million CNY | -10.0% |
| 2009 Q2 | 331.99 Million CNY | 13.2% |
| 2009 Q1 | 293.27 Million CNY | -24.03% |
| 2008 FY | - CNY | 37.48% |
| 2008 Q2 | 346.77 Million CNY | 58.56% |
| 2008 Q1 | 218.69 Million CNY | -3.8% |
| 2008 Q3 | 189.9 Million CNY | -45.24% |
| 2008 Q4 | 386.04 Million CNY | 103.28% |
| 2007 Q4 | 227.34 Million CNY | 88.13% |
| 2007 Q3 | 120.84 Million CNY | -52.46% |
| 2007 Q1 | 110.18 Million CNY | -59.23% |
| 2007 Q2 | 254.18 Million CNY | 130.7% |
| 2007 FY | - CNY | -3.11% |
| 2006 Q1 | 309.36 Million CNY | 34.83% |
| 2006 Q2 | 251.07 Million CNY | -18.84% |
| 2006 Q3 | 281.7 Million CNY | 12.2% |
| 2006 FY | - CNY | 2.69% |
| 2006 Q4 | 270.27 Million CNY | -4.06% |
| 2005 Q4 | 229.45 Million CNY | -24.08% |
| 2005 FY | - CNY | 53.87% |
| 2005 Q1 | 312 Million CNY | 207.22% |
| 2005 Q2 | 212.88 Million CNY | -31.77% |
| 2005 Q3 | 302.21 Million CNY | 41.96% |
| 2004 Q1 | 234.64 Million CNY | 69.07% |
| 2004 Q4 | 101.55 Million CNY | -42.92% |
| 2004 FY | - CNY | -10.23% |
| 2004 Q3 | 177.93 Million CNY | -9.61% |
| 2004 Q2 | 196.84 Million CNY | -16.11% |
| 2003 Q2 | 243.07 Million CNY | 8.97% |
| 2003 FY | - CNY | 12.7% |
| 2003 Q1 | 223.07 Million CNY | 86.18% |
| 2003 Q4 | 138.78 Million CNY | -25.96% |
| 2003 Q3 | 187.46 Million CNY | -22.88% |
| 2002 Q4 | 119.81 Million CNY | 24.21% |
| 2002 FY | - CNY | 10.25% |
| 2002 Q3 | 96.46 Million CNY | -16.61% |
| 2002 Q2 | 115.67 Million CNY | -8.54% |
| 2002 Q1 | 126.48 Million CNY | 0.0% |
| 2001 FY | - CNY | 9.93% |
| 2000 FY | - CNY | 27.51% |
| 1999 FY | - CNY | 25.74% |
| 1998 FY | - CNY | 57.74% |
| 1997 FY | - CNY | 0.62% |
| 1996 FY | - CNY | -2.67% |
| 1995 FY | - CNY | -86.69% |
| 1994 FY | - CNY | 623.44% |
| 1993 FY | - CNY | 0.0% |